Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
diptheria vaccine, toxin/antitoxin mixtures (tat) (2018 NDA)
Tetanus and diphtheria toxoids adsorbed (Decavac) (1970 NDA)
mbl-hcv1 (3 trials)
sodium chloride (3 trials)
sofosbuvir (sovaldi) (1 trial)
telaprevir (incivek) (1 trial)
2217ls (1 trial)
s315 (1 trial)
Diphtheria (Phase 1)
Hepatitis (Phase 2)
Hepatitis A (Phase 2)
Hepatitis C (Phase 2)
Trials (5 total)
Trial APIs (6 total)